Development of anisoylated plasminogen-streptokinase activator complex from the acyl enzyme concept.
Fears
R
R
Beecham Pharmaceuticals Research Division, Epsom, Surrey, United Kingdom.
D000818:Animals; D016255:Anistreplase; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010958:Plasminogen / Q000008:administration & dosage* / Q000378:metabolism / Q000493:pharmacokinetics; D013300:Streptokinase / Q000008:administration & dosage* / Q000493:pharmacokinetics
D005343:Fibrinolytic Agents; D016255:Anistreplase; D005337:Fibrin; D010958:Plasminogen; D013300:Streptokinase